{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:58:42Z","timestamp":1761919122035},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mehy.2008.01.031","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T12:23:34Z","timestamp":1207225414000},"page":"85-90","source":"Crossref","is-referenced-by-count":42,"title":["A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10"],"prefix":"10.1016","volume":"71","author":[{"given":"Colleen E.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Donald Acheson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2008.01.031_bib1","first-page":"554","article-title":"Histologie de la slcerose en plaques","volume":"41","author":"Charcot","year":"1868","journal-title":"Gazette des hopitaux, Paris"},{"key":"10.1016\/j.mehy.2008.01.031_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nm0305-252","article-title":"Multiple sclerosis: trapped in deadly glue","volume":"11","author":"Platten","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2008.01.031_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(00)00444-6","article-title":"Multiple sclerosis: genomic rewards","volume":"113","author":"Oksenberg","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"Suppl. 147","key":"10.1016\/j.mehy.2008.01.031_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0447.1960.tb08674.x","article-title":"Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables","volume":"35","author":"Acheson","year":"1960","journal-title":"Acta Psychiatry (Scandanavia)"},{"key":"10.1016\/j.mehy.2008.01.031_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/oem.57.6.418","article-title":"Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates","volume":"57","author":"Freedman","year":"2000","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.mehy.2008.01.031_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jech.58.2.142","article-title":"Multiple sclerosis, solar radiation and skin cancer: a record linkage study","volume":"58","author":"Goldacre","year":"2004","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.mehy.2008.01.031_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000054783","article-title":"Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation","volume":"20","author":"van der Mei","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2008.01.031_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.327.7410.316","article-title":"Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study","volume":"327","author":"van der Mei","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2008.01.031_bib9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","article-title":"Enzymes involved in the activation and inactivation of vitamin D","volume":"29","author":"Prosser","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.mehy.2008.01.031_bib10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25-dihydroxyvitamin D3 receptors in human leukocytes","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.mehy.2008.01.031_bib11","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","article-title":"Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation","volume":"57","author":"Bhalla","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2008.01.031_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis","volume":"216","author":"Hayes","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.mehy.2008.01.031_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S0029665100000768","article-title":"Vitamin D: a natural inhibitor of multiple sclerosis","volume":"59","author":"Hayes","year":"2000","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.mehy.2008.01.031_bib14","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2008.01.031_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-5728(99)00247-7","article-title":"1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis","volume":"103","author":"Nashold","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(01)00360-5","article-title":"Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis","volume":"119","author":"Nashold","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib17","first-page":"277","article-title":"The immunological functions of the vitamin D endocrine system","volume":"49","author":"Hayes","year":"2003","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.mehy.2008.01.031_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1152\/physiolgenomics.00003.2004","article-title":"25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis","volume":"18","author":"Spach","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.mehy.2008.01.031_bib19","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.175.6.4119","article-title":"Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice","volume":"175","author":"Spach","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib20","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","article-title":"IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis","volume":"177","author":"Spach","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib21","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/jnr.21382","article-title":"1,25-dihydroxyvitamin D(3) reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking","volume":"85","author":"Pedersen","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mehy.2008.01.031_bib22","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2008.01.031_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp.2006.105320","article-title":"A longitudinal study of serum 25-hydroxyvitamin D and intact PTH levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis","volume":"79","author":"Soilu-Hanninen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2008.01.031_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1531-8249(200008)48:2<271::AID-ANA28>3.0.CO;2-O","article-title":"Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis","volume":"48","author":"Embry","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2008.01.031_bib25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.ejcn.1601952","article-title":"Multiple sclerosis and vitamin D: an update","volume":"58","author":"VanAmerongen","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.mehy.2008.01.031_bib26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2008.01.031_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri701","article-title":"The enemy within: keeping self-reactive T cells at bay in the periphery","volume":"2","author":"Walker","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2008.01.031_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","article-title":"FOXP3: of mice and men","volume":"24","author":"Ziegler","year":"2006","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib30","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.163.11.6338","article-title":"Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10","volume":"163","author":"Stohlman","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4049\/jimmunol.170.3.1240","article-title":"Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo","volume":"170","author":"Sundstedt","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/intimm\/dxh029","article-title":"IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+ CD4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib33","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","article-title":"Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+ CD25+ regulatory cells within the central nervous system","volume":"175","author":"McGeachy","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib35","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.178.6.3447","article-title":"B cell regulation of CD4+ CD25+ T-regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis","volume":"178","author":"Mann","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2008.01.031_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1615\/CritRevImmunol.v21.i5.20","article-title":"Interleukin-10 in the brain","volume":"21","author":"Strle","year":"2001","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jneuroim.2006.09.014","article-title":"Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway","volume":"183","author":"Christensen","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/oxfordjournals.bmb.a071407","article-title":"Epidemiology of multiple sclerosis","volume":"33","author":"Acheson","year":"1977","journal-title":"Br Med Bull"},{"key":"10.1016\/j.mehy.2008.01.031_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0306-9877(88)90024-2","article-title":"Multiple sclerosis etiology \u2013 an Epstein-Barr virus hypothesis","volume":"25","author":"Warner","year":"1988","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2008.01.031_bib41","first-page":"4","article-title":"Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease","volume":"12","author":"Fatheringham","year":"2005","journal-title":"Herpes"},{"key":"10.1016\/j.mehy.2008.01.031_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2008.01.031_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.58.1.31","article-title":"A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS","volume":"58","author":"Bech","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2008.01.031_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1471-4906(01)02149-4","article-title":"The interleukin-10 family of cytokines","volume":"23","author":"Fickenscher","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib45","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.2161559","article-title":"Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI","volume":"248","author":"Moore","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mehy.2008.01.031_bib46","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.2173142","article-title":"Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1","volume":"250","author":"Hsu","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mehy.2008.01.031_bib47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.str.2005.01.016","article-title":"Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain","volume":"13","author":"Yoon","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.mehy.2008.01.031_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mehy.2007.04.030","article-title":"Vitamin D status modulates the immune response to Epstein-Barr virus: Synergistic effect of risk factors in multiple sclerosis","volume":"70","author":"Holmoy","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2008.01.031_bib50","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0092-8674(00)81678-5","article-title":"CD46 is a cellular receptor for human herpesvirus 6","volume":"99","author":"Santoro","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2008.01.031_bib51","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI29251","article-title":"Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis","volume":"116","author":"Astier","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2008.01.031_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/rmv.503","article-title":"Multiple sclerosis is linked to Epstein-Barr virus infection","volume":"16","author":"Haahr","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.mehy.2008.01.031_bib53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2008.01.031_bib54","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/514141","article-title":"Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection","volume":"176","author":"Tanner","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2008.01.031_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(00)00355-6","article-title":"MRI activity and interferon-beta-1a therapy in patients with relapsing-remitting MS","volume":"112","author":"Waubant","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib56","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.44.8.1523","article-title":"Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis","volume":"44","author":"Rieckmann","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2008.01.031_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0923-2494(97)84408-2","article-title":"The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis","volume":"147","author":"Musette","year":"1996","journal-title":"Res Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R","article-title":"Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis","volume":"45","author":"van Boxel-Dezaire","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2008.01.031_bib59","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/1531-8249(200010)48:4<641::AID-ANA11>3.0.CO;2-Z","article-title":"Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis","volume":"48","author":"de Jong","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2008.01.031_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2249.2000.01175.x","article-title":"Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment","volume":"120","author":"Ozenci","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jnr.1209","article-title":"Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene","volume":"66","author":"Vandenbark","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mehy.2008.01.031_bib62","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2008.01.031_bib63","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+ CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2008.01.031_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J Neurosci Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708000613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708000613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T12:09:43Z","timestamp":1684325383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987708000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0306987708000613"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2008.01.031","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}